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Abstract
Purpose High-grade disease accounts for ~ 70% of all glioma, and has a high mortality rate. Few modifiable exposures are
known to be related to glioma risk or mortality.
Methods We examined associations between lifetime physical activity and physical activity at different ages (15–18 years,
19–29 years, 30–39 years, last 10 years) with the risk of glioma diagnosis, using data from a hospital-based family case–control study (495 cases; 371 controls). We followed up cases over a median of 25 months to examine whether physical activity
was associated with all-cause mortality. Physical activity and potential confounders were assessed by self-administered
questionnaire. We examined associations between physical activity (metabolic equivalent [MET]-h/wk) and glioma risk
using unconditional logistic regression and with all-cause mortality in cases using Cox regression.
Results We noted a reduced risk of glioma for the highest (≥ 47 MET-h/wk) versus lowest (< 24 METh/wk) category of
physical activity for lifetime activity (OR = 0.58, 95% CI: 0.38–0.89) and at 15–18 years (OR = 0.57, 95% CI: 0.39–0.83). We
did not observe any association between physical activity and all-cause mortality (HR for lifetime physical activity = 0.91,
95% CI: 0.64–1.29).
Conclusion Our findings are consistent with previous research that suggested physical activity during adolescence might be
protective against glioma. Engaging in physical activity during adolescence has many health benefits; this health behavior
may also offer protection against glioma.
Keywords Physical activity · Glioma · Case–control study · Survival

Introduction
Gliomas are a heterogeneous group of primary central nervous system (CNS) tumors that originate from glial stem cells
or precursor cells [1]. Rarely metastasizing beyond the CNS,
glioma is generally classified as low grade (World Health
Organization [WHO] grade 1 or 2) or high grade (WHO
grade 3 or 4) rather than benign/malignant. Unlike most
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cancers, survival rates for high grade brain tumors have not
improved over the last decade.
High-grade disease accounts for ~ 70% of all glioma [2–4]
and although low in incidence, carries a disproportionately
high mortality rate, a high social burden to both the cancer
sufferer and carer, and high costs for the healthcare system.
Glioblastoma is by far the most common high grade glioma
and has a median survival rate of less than 15 months [5, 6].
While low grade glioma carries a much better prognosis [4,
6–11], 70% of low grade gliomas will progress to high grade
glioma within 5–10 years of initial diagnosis [8].
The relatively low incidence of glioma, short survival
time for the most common (grade IV) glioma grade, and
high morbidity associated with the disease makes it difficult
to undertake epidemiological studies to identify risk factors
and any modifiable factors associated with longer survival.
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Gliomas are more common in older adults, men, Caucasians
and individuals with some rare hereditary syndromes including neurofibromatosis (type 1 and type 2) and the tuberous
sclerosis complex [12, 13]. The only well-established modifiable risk factor is ionizing radiation, but this only accounts
for a small fraction of gliomas [14].
The NIH-AARP Diet and Health Study demonstrated an
inverse association between physical activity at age 15–18
and risk of glioma (RR for ≥ 52 vs ≤ 12 metabolic equivalent
[MET]-h/wk = 0.64; 95% CI = 0.44–0.93), however no association was found for physical activity undertaken at older
ages [12]. In contrast, the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study did not
find any associations between physical activity and glioma
[15]. Similarly, the National Cancer Institute Cohort Consortium Physical Activity Pooling Project (which harmonized
data from 1.44 million cohort study participants across the
USA and Europe) did not find evidence of an association
between physical activity during adulthood and brain cancer
(glioma was not examined separately) [16].
Age at diagnosis, tumor grade, extent of surgical resection, performance status, and treatment undertaken are
established predictors of mortality following a glioma diagnosis [17]. The influence of modifiable factors, other than
treatment, on the outcome of glioma is largely unknown
[18]. Only one study has examined the association between
physical activity after a diagnosis of glioma and survival.
Two hundred and forty-three adults with grade 3 or 4 glioma were followed for a median of 27 months; participating
in ≥ 9 vs < 9 MET-h/wk after diagnosis was associated with
a lower risk of death (HR = 0.64; 95% CI: 0.46–0.91) and a
median survival time of 22 compared with 13 months [19].
However, observational studies of post-diagnosis physical
activity in cancer survivors are prone to considerable reverse
causation, and should be interpreted with caution [20].
We conducted a hospital-based family case–control study
to assess the association of physical activity with both risk of
glioma and mortality following a glioma diagnosis.

Materials and methods
Study sample
Cases were aged between 18 and 80 years, resident in
one of five Australian states (New South Wales, Victoria, Queensland, Western Australia or Tasmania) and
diagnosed between March, 2013 and May, 2017. Cases
were recruited via collaborative clinical networks including public and private hospitals with general or specialist
neuro-oncology clinics. Clinical trial sites represented the
majority, or in some juridictions the only, service for the
investigation and treatment of neurological cancers. Cases
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were diagnosed with cranial glioma low grade (grade I or
II; 16%), high grade (grade III or IV; 72%) or unknown
grade (11%).
Controls were recruited from family members (siblings and/or partners) of cases. When a case had multiple
siblings, and consented to all of them being approached,
when available the sibling of the same sex and closest
in age to the case was initially approached. Of those
approached by the study coordinating center to participate, 172 cases and 147 controls could not be contacted.
A total of 655 cases enrolled in the study (83.4%) and 130
refused (16.6%); the corresponding numbers of controls
were 392 (81.0%) and 92 (19.0%). Of these, 495 cases and
371 controls fully completed the risk factor questionnaires.
Figure 1 describes the recruitment to the study, for both
the case–control and survival analyses.

Data collection
Data for the study were collected by self-completed questionnaire following the construction of a ‘lifetime residence
and work calendar’ to help minimize recall error.
Exposure variables
Participants reported the amount of time they had typically
spent (h/wk) performing light-intensity physical activity (examples provided: bowling, golf (cart), table tennis,
slow walking/dancing, light gardening, light housework,
fishing, light calisthenics) and moderate- to vigorousintensity physical activity (MVPA; examples provided:
tennis, cycling, swimming, heavy gardening, weight lifting, running, aerobics, fast walking, heavy housework,
basketball, football, rowing, fast dancing, hiking, racquetball) at ages 15–18 years, 19–29 years, 30–39 years and
during the 10 years prior to diagnosis or completion of the
questionnaire (controls). Seven response options were provided: never, rarely, weekly but < 1 h/wk, 1–3 h/wk, 4–7 h/
wk, > 7 h/wk, and do not know.
We generated a quasi-continuous total physical activity
variable in MET-h/wk for each age group using the formula: hours of light physical activity (median value within
response options) * 3 (METs) + hours of moderate/vigorous
activity (median value within response options) * 5 (METs).
A lifetime physical activity variable was created by summing
the quasi-continuous variables from applicable age periods
and dividing by that number. Categorical variables were created for physical activity at each age and lifetime physical
activity, based on the underlying distribution of the quasicontinuous variables in the controls: < 24 MET-h/wk (ref),
24–< 47 MET-h/wk, ≥ 47 MET-h/wk.
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Fig. 1  Flow of participants through the study

Potential confounders
We generated directed acyclic graphs (DAGs) [21] to help
guide decisions for the inclusion of confounders in our multivariable models. While physical activity was reported at
different ages, data on potential confounding variables were
reported either for the year prior to diagnosis or at the time
of interview. The variables considered as confounders for
different models for glioma risk are presented in Supplementary Fig. S1. Potential confounders included: age (years);
sex (male, female); ethnicity/race (Caucasian, other);
income (< $50,000AUD per year, $50,000–$100,000AUD
per year, > $100,000AUD per year); education attainment
(completed high school, some university or vocational
training, completed university degree); screen time (≤ 18 h/
wk, > 18–25 h/wk, > 25 h/wk); alcohol consumption (gm/
wk); and smoking status (never, former, current regular
smoker at least for 12 months).
We considered body mass index (BMI) to be a mediator
in our main models, but we performed sensitivity analyses
to model BMI as a confounder. Because BMI had only been
assessed for the year prior to diagnosis (cases) or completion
of the questionnaire (controls), we only conducted this sensitivity analysis for the models examining physical activity
during the last 10 years or lifetime physical activity. In our
sensitivity analyses we also included potential confounders
that were not assessed for the same age periods as physical activity. Education and income reflect socioeconomic
position, which is often stable across the life course [22].

Similarly, drinking and smoking habits are often established
in late adolescence or early adulthood [23]. For the sensitivity analyses we also adjusted for age in all models, not just
those examining physical activity during the last 10 years or
lifetime physical activity.
For survival analyses, we considered previous cancer
diagnoses as a potential confounder. Again, BMI was primarily considered a mediator, but we adjusted for this variable in sensitivity analyses (See DAG Supplementary Fig.
S2). Tables summarizing the hypothesized underlying confounding structure for the case–control and survival analyses
are presented in Supplementary Tables S1 and S2.
All‑cause mortality
Deaths were ascertained through record linkage to the Victorian Registry of Births, Deaths and Marriages, and the
National Death Index at the Australian Institute of Health
and Welfare. The National Death Index is a high-quality,
population-based registry compiled from Registry of Births,
Deaths and Marriages data supplied by each state and territory. The Australian Institute of Health and Welfare uses
probabilistic record linkage based on full name, date of
birth, sex, date of last contact, and address; deterministic
linkage is not possible in Australia because we do not have
a unique personal identification number. While vital status
was ascertained for all participants, cause of death was not
available for all due to some juridstictions having a delay of
several years to complete adjudication.
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were performed using STATA software version 15.1 (Stata
Corp, College Station, TX).

Statistical analysis
Case–control analyses
We examined the associations for the quasi-continuous physical activity measure (per 10 MET-h/wk) and the categorical
measures of total physical activity at each age and over the
lifetime. Primary and sensitivity analyses were adjusted for
different potential confounders, as summarized in Supplementary Table 1. We used unconditional logistic regression
models for an unmatched design, and applied the vce(cluster
clustvar) option in the model to allow for clustering within
families for sibling controls.
Survival analyses
We calculated overall survival as the number of months from
diagnosis to death or last update of vital status (as one common censoring date for all patients). Cox proportional hazards regression was used to estimate multivariate HRs and
95% CI. We tested the proportional hazards assumption by
including an interaction term between time and the covariates and assessed the statistical significance of the interaction terms. In the instance of violating the proportional hazards assumption, the corresponding variable remained with
the interaction term in the model.
For cases and controls, there was 18% and 20% missingness in the physical activity data for the past 10 years and
ages 30–39 years, and 14% and 15% for the ages 19–29 and
15–18 years. Multiple imputation by chained Eqs. (25 imputations) was used to impute missing data under the assumption that the data were missing at random [26]. All analyses
Table 1  Characteristics of cases
(n = 495) and controls (n = 371)
in the glioma family case–
control study

Results
This study involved 495 glioma cases and 371 controls;
cases and controls were very similar in age and BMI, however 63% of the cases and 38% of controls were men. Table 1
presents the characteristics of the study participants.
Table 2 presents the results from the case–control
study examining associations between the quasi-continuous measure of physical activity at each age and for lifetime physical activity. Lower risk of developing glioma
were associated with physical activity at age 15–18 years
(ORper 10 MET-h/wk = 0.88, 95% CI: 0.80–0.96) and for lifetime physical activity (ORper 10 MET-h/wk = 0.89, 95% CI:
0.80–0.99). Table 2 also presents the results for categories of
physical activity. Lower risks of glioma were associated with
the highest category of activity (≥ 47 MET-h/wk versus < 24
MET-h/wk) during adolescence (15–18 years; OR = 0.57,
95% CI: 0.39–0.83), as well as lifetime activity (OR = 0.58,
95% CI: 0.38–0.89). The results of the sensitivity analyses
did not materially differ from the primary analyses (results
not shown).
Cases were followed up for a median of 25 months, with
an interquartile range of 14–43 months. Cause of death was
available for 412 cases; 401 deaths were due to brain cancer (97%). Table 3 presents results from Cox proportional
hazards regression models, which show that pre-diagnosis
physical activity was not associated with all-cause mortality
at any time period (Table 3). The results of the sensitivity

Participant characteristics

Cases

Controls

Participants (n)
Days between diagnosis and consent, mean (SD)
Age (years), mean (SD)
Men, n (%)
BMI (kg/m2), mean (SD)
Caucasians, n (%)
College education, n (%)
High income, n (%)
Current smokers, n (%)
Alcohol (grams/wk), median (IQR)
Physical activity in past 10 years (MET-h/wk), mean (SD)
< 24 MET-h/wk (ref) physical activity in last 10 years, n (%)
24–< 47 MET-h/wk physical activity in past 10 years, n (%)
≥ 47 MET-h/wk physical activity in past 10 years, n (%)
Lifetime physical activity, (MET-h/wk), mean (SD)
Screen time in one year before diagnosis (h/wk), mean (SD)

495
92.5 (171.3)
54.2 (14.5)
312 (63.0)
27.7 (5.7)
447 (91.0)
161 (32.7)
121 (28.7)
47 (9.7)
49 (128)
32.2 (18.2)
152 (38.4)
117 (29.6)
127 (32.1)
34.4 (15.2)
20.9 (6.4)

371
–
54.3 (13.5)
140 (37.7)
27.0 (5.1)
351 (94.9)
142 (38.3)
119 (37.7)
23 (6.3)
54 (139)
34.0 (17.0)
94 (29.9)
111 (35.4)
109 (34.7)
36.0 (14.7)
21.4 (6.0)

All statistics in the table are based on the complete case data prior to multiple imputation
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Table 2  Odds ratios and 95% confidence intervals for glioma diagnosis in relation to physical activity at different ages and lifetime physical
activity in Australia (2012–2014)
Cases in origi- Cases after multinal dataset*
ple imputation**
Previous 10 years (per 10 MET-h/wk)a
< 24 MET-h/wk (ref)a
24–< 47 MET-h/wk
≥ 47 MET-h/wk
30–39 years of age (per 10 MET-h/wk)b
< 24 MET-h/wk (ref)b
24–< 47 MET-h/wk
≥ 47 MET-h/wk
19–29 years of age (per 10 MET-h/wk)b
< 24 MET-h/wk (ref)b
24–< 47 MET-h/wk
≥ 47 MET-h/wk
15–18 years of age (per 10 MET-h/wk)c
< 24 MET-h/wk (ref)c
24–< 47 METh/wk
≥ 47 MET-h/wk
Lifetime activity (per 10 MET-h/wk)a
< 24 MET-h/wk (ref)a
24–< 47 MET-h/wk
≥ 47 MET-h/wk
*

b
c
d

494
191
150
153
494
163
183
148
494
132
197
165
494
164
155
175
494
140
237
117

Model 2

OR (95% CI)

P value

OR (95% CI)

P value

0.95 (0.87–1.04)
1.00
0.74 (0.52–1.06)
0.78 (0.53–1.14)
0.94 (0.86–1.03)
1.00
1.05 (0.71–1.54)
0.71 (0.48–1.05)
0.92 (0.84–1.01)
1.00
1.05 (0.71–1.56)
0.73 (0.49–1.08)
0.88 (0.80–0.96)
1.00
0.74 (0.51–1.06)
0.57 (0.39–0.83)
0.89 (0.80–0.99)
1.00
0.82 (0.55–1.21)
0.58 (0.38–0.89)

0.269

0.95 (0.87–1.04)
1.00
0.74 (0.51–1.07)
0.78 (0.53–1.14)
0.94 (0.86–1.03)
1.00
1.04 (0.71–1.55)
0.71 (0.48–1.04)
0.92 (0.84–1.01)
1.00
1.04 (0.70–1.55)
0.72 (0.48–1.07)
0.88 (0.81–0.96)
1.00
0.79 (0.54–1.16)
0.59 (0.40–0.87)
0.89 (0.80–0.99)
1.00
0.82 (0.55–1.22)
0.58 (0.38–0.89)

0.284

0.102
0.196
0.187
0.818
0.086
0.082
0.808
0.116
0.003
0.101
0.003
0.031
0.321
0.012

0.107
0.203
0.190
0.826
0.082
0.069
0.846
0.102
0.006
0.227
0.007
0.033
0.322
0.013

Number of cases in the unimputed dataset

**
a

396
152
117
127
381
123
143
115
415
108
166
141
408
133
125
150
334
93
151
90

Model 1

Averaged number of cases in each imputed dataset included in the analysis

Model 1 adjusted for age, sex, ethnicity, income, education, screen time, smoking, alcohol; model 2 additionally adjusted for BMI
Model 1 adjusted for sex, ethnicity, income, education; model 2 additionally adjusted for age, screen time, smoking and alcohol
Model 1 adjusted for sex, ethnicity; model 2 additionally adjusted for age, income, education, screen time, smoking and alcohol
Model 1 adjusted for sex, ethnicity; model 2 additionally adjusted for age, alcohol, smoking, income, education, screen time

analyes did not materially differ from the primary analyses
(results not shown).

Discussion
We used a hospital-based family case–control study to examine associations between physical activity performed at different ages and intensity and lifetime physical activity and
glioma risk. Greater physical activity at age 15–18 years,
and over the lifetime was associated with lower risk of developing glioma. Pre-diagnosis physical activity was not associated with all-cause mortality for cases.
Recruitment to the case–control study was challenging,
due to the morbidity and mortality associated with glioma
and its treatment. Given that the median survival for (the
most common high grade glioma) is less than 15 months
[5, 6], and that it took three months on average to consent
cases who participated in this study, it is highly likely that
our sample does not include people diagnosed with the most

aggressive or difficult to manage gliomas. This selection
bias will have affected both the case–control and survival
analyses. We accounted for differences between genetically
related controls (siblings) and non-genetically related controls (partners and other controls) in our analyses, and the
use of different types of controls did not affect the results.
Other methodological challenges may also have introduced
bias. Adults generally overestimate their physical activity
compared with estimates derived from accelerometry [27].
We asked participants to recall the type, frequency and
duration of physical activity they performed decades ago.
Although we used a ‘lifetime residence and work calendar’
to help prompt memory, substantial recall error was likely.
As a result, the study findings may have been affected by
non-differential and differential measurement error.
A number of the confounding factors were not available
for each time period. While some would remain relatively
stable across the life course (e.g., educational attainment),
some may change considerably over time. It would have
been useful to have measures of BMI for the different time
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Table 3  Hazard ratios and
95% confidence intervals for
all-cause mortality following
glioma diagnosis in relation to
physical activity at different
ages and lifetime physical
activity

Past 10 years (10 MET-h/wk)a
< 24 MET-h/wk (ref)a
24—< 47 MET-h/wk
≥ 47 MET-h/wk
30–39 years of ageb
< 24 MET-h/wk (ref)b
24–< 47 MET-h/wk
≥ 47 MET-h/wk
19–29 years of agec
< 24 MET-h/wk (ref)c
24–< 47 MET-h/wk
≥ 47 MET-h/wk
15–18 years of aged
< 24 MET-h/wk (ref)d
24–< 47 MET-h/wk
≥ 47 MET-h/wk
Lifetime activitya
< 24 MET-h/wk (ref)a
24–< 47 MET-h/wk
≥ 47 MET-h/wk
*
a

No. deaths/
person
months

Model 1

Model 2

HR (95% CI)

P value

HR (95% CI)

P value

332/14,998
131/5,786
102/4,369
99/4,844
332/1,4998
116/4,834
119/5,693
97/4,472
332/14,998
88/4,129
140/5,738
104/5,131
332/14,998
117/5,059
99/4,744
116/5,195
332/14,998
98/4,398
162/6,804
72/3,796

0.97 (0.91–1.04)
1.00
0.91 (0.68–1.23)
0.89 (0.67–1.18)
1.00 (0.93–1.07)
1.00
0.85 (0.64–1.13)
0.96 (0.71–1.29)
0.99 (0.93–1.06)
1.00
1.18 (0.89–1.56)
1.02 (0.75–1.39)
0.98 (0.92–1.05)
1.00
0.85 (0.64–1.13)
0.94 (0.71–1.23)
0.98 (0.90–1.06)
1.00
1.02 (0.71–1.37)
0.91 (0.64–1.29)

0.335

0.99 (0.92–1.06)
1.00
0.96 (0.71–1.30)
0.95 (0.71–1.27)
0.96 (0.90–1.03)
1.00
0.75 (0.56–1.01)
0.83 (0.61–1.13)
0.99 (0.92–1.06)
1.00
1.20 (0.90–1.60)
1.03 (0.75–1.42)
1.01 (0.95–1.08)
1.00
0.92 (0.68–1.24)
1.09 (0.81–1.47)
0.99 (0.92–1.08)
1.00
1.07 (0.80–1.43)
0.98 (0.68–1.39)

0.725

0.542
0.420
0.958
0.269
0.776
0.747
0.264
0.896
0.599
0.256
0.634
0.590
0.870
0.606

0.776
0.739
0.284
0.060
0.244
0.727
0.211
0.851
0.715
0.583
1.578
0.865
0.659
0.893

Number of deaths/person months is the average across 25 multiple imputed datasets

Model 1 adjusted for age, sex, ethnicity, income, education, alcohol, smoking, personal cancer history
(excluding non-melanoma skin cancer) and screen time; model 2 additionally adjusted for BMI

b

Model 1 adjusted for sex, ethnicity, income, education and personal cancer history (excluding non-melanoma skin cancer); model 2 additionally adjusted for age, alcohol, smoking and screen

c

Model 1 adjusted for sex, ethnicity, income, education; model 2 additionally adjusted for age, alcohol,
smoking and screen time

periods at which physical activity was reported, given the
hypothesis that early life energy balance (affected by both
BMI and physical activity) is a risk factor for glioma. The
BMI estimate at time of interview (for cases) might have
been affected by dexamethasone (steroid) use for the management of their disease.
We observed a strong and significant association
between physical activity during adolescence and lower
glioma risk. This is consistent with findings from the
NIH-AARP Diet and Health Study, which demonstrated
an inverse association between physical activity at age
15–18 and risk of glioma [12]. The point estimate presented by Moore et al. for the highest vs. lowest category
of physical activity between ages 15 to 18 years was 0.64
(95% CI: 0.43–0.94), which is very similar to our result
(OR = 0.57, 95% CI: 0.39–0.83). Both the NIH-AARP
Diet and Heath Study and ours used a broad and inclusive
measure of physical activity, assessing light and moderatevigorous activities not restricted to any behavioral domain.
The consistency of these findings supports the premise
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that being highly active—regardless of type or intensity
of activity—during adolescence may reduce glioma risk.
Other research on physical activity and brain/central nervous system tumors is limited, and contradictory. In the Million Women cohort study, an inverse association between
strenuous exercise and incidence of all central nervous system tumors, meningioma and glioma was observed [28]. In
contrast, neither the EPIC cohort study [15] nor the National
Cancer Institute Cohort Consortium Physical Activity Pooling Project [16] reported evidence of an association between
physical activity during adulthood and brain cancer.
It has been proposed that the associations of body mass,
height and physical activity with risk of glioma may be
related to early life energy balance, and subsequent influences on circulating insulin levels [12]. Hyper-insulinemia
may be caused by obesity and low levels of physical activity. Insulin is known to have a promitotic effect and in vivo
experiments have shown that dietary hyperinsulinemia is
associated with cell proliferation and tumor growth [29].
Insulin increases the levels of free circulating insulin-like

Cancer Causes & Control

growth factor-1 (IGF-1) in the body by binding to the receptors of IGF-1 [12, 29]. IGF-1 plays a crucial role as a neurotrophic factor in the early development of the peripheral
and central nervous systems [12, 30]. Considering the role
of IGF-1 in the proliferation, differentiation and apoptosis of
glial cells, it is biologically plausible that physical inactivity, including in earlier life, may contribute to glioma risk.
To date only one study has examined physical activity and
mortality after a glioma diagnosis. Ruden et al. reported a
reduced risk associated with post-diagnosis physical activity
[19], but the robustness of these findings is challenged by
reverse causation. Our findings suggest that physical activity performed across the life course is not associated with
mortality following a glioma diagnosis. Previous research
has shown that pre-morbid obesity was associated with
reduced overall survival in patients with high-grade glioma
[18], supporting the concept that energy balance may play
a role in survival. Further, it is increasingly understood
that many chronic diseases, which contribute to mortality
rates in populations affected by cancer, begin developing in
childhood and adolescence, highlighting the need to consider a life course approach [31]. Therefore further research
(ideally, randomized-controlled trials) is crucial to clarify
whether physical activity can help extend survival for glioma
patients.

Conclusion
Few studies have explored associations between physical
activity and glioma, a relatively uncommon cancer. Our
study suggests that physical activity, particularly during
adolescence, may reduce the risk of glioma later in life.
Pre-diagnosis physical activity did not appear to influence
survival after a glioma diagnosis. These findings strengthen
the argument that physical inactivity is an important and
modifiable glioma risk factor to be addressed by public
health interventions.
Supplementary Information The online version contains supplementary material available at https://d oi.o rg/1 0.1 007/s 10552-0 22-0 1559-w.
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